1. Home
  2. LOAN vs NEPH Comparison

LOAN vs NEPH Comparison

Compare LOAN & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.44

Market Cap

48.2M

Sector

Real Estate

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.30

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOAN
NEPH
Founded
1989
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
40.1M
IPO Year
1999
2004

Fundamental Metrics

Financial Performance
Metric
LOAN
NEPH
Price
$4.44
$3.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
16.5K
11.3K
Earning Date
04-16-2026
05-08-2026
Dividend Yield
10.06%
N/A
EPS Growth
N/A
1000.00
EPS
0.11
0.01
Revenue
$8,666,307.00
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
$40.18
$326.00
Revenue Growth
N/A
32.67
52 Week Low
$4.13
$2.66
52 Week High
$5.85
$6.42

Technical Indicators

Market Signals
Indicator
LOAN
NEPH
Relative Strength Index (RSI) 61.00 46.22
Support Level $4.41 $2.77
Resistance Level $4.48 $3.79
Average True Range (ATR) 0.08 0.18
MACD 0.02 -0.03
Stochastic Oscillator 83.91 19.72

Price Performance

Historical Comparison
LOAN
NEPH

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: